Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g.
Maier RF, Obladen M, Müller-Hansen I, Kattner E, Merz U, Arlettaz R, Groneck P, Hammer H, Kössel H, Verellen G, Stock GJ, Lacaze-Masmonteil T, Claris O, Wagner M, Matis J, Gilberg F; European Multicenter Erythropoietin Beta Study Group.
Maier RF, et al. Among authors: muller hansen i.
J Pediatr. 2002 Jul;141(1):8-15. doi: 10.1067/mpd.2002.124309.
J Pediatr. 2002.
PMID: 12091844
Clinical Trial.